Results Over the 5-year horizon of this study, the projections of HCC annual prevalence (including patients in remission) show an increasing trend, rising from 4,151 in 2023 to 4,851 in 2027.
← all excerpts
Adhering to the Barcelona Clinic Liver Cancer Disease Staging and Treatment Algorithm: Disease Burden and Cost of Illness of Hepatocellular Carcinoma in Portugal.
1
—
—